IPRIPR2023-00512Terminated-Settled
Apotex Inc. et al.v.CELGENE CORPORATION et al.
IPR challenge of US 8846628.
Type
IPR
Filed
Feb 10, 2023
Instituted
Jul 20, 2023
Decided
Jan 5, 2024
Patent
Application
12466213
Inventor
Jeffrey B. Etter et al
Granted
Sep 30, 2014
01
Timeline
3 milestones
2023-02-10Petition filed
2023-07-20Institution
2024-01-05Terminated
02
Parties & counsel
Petitioner
Apotex Inc. et al.
Counsel
Gupta, Vishalet al
Patent Owner
CELGENE CORPORATION et al.
Counsel
Petruzzi, Heatheret al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →